The largest database of trusted experimental protocols

Anti vimentin v9

Manufactured by Agilent Technologies
Sourced in United States

Anti-vimentin (V9) is a mouse monoclonal antibody that recognizes the vimentin protein, which is a type III intermediate filament. Vimentin is often used as a marker for mesenchymal cells and is expressed in a variety of cell types, including fibroblasts, endothelial cells, and certain cancer cells. The V9 clone is a commonly used anti-vimentin antibody for immunohistochemical and immunocytochemical applications.

Automatically generated - may contain errors

4 protocols using anti vimentin v9

1

Immunofluorescence Staining and Imaging of Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For Figure 1, ANA staining patterns of TIN mAbs were visualized using an IIF kit (INOVA diagnostics). For subsequent studies, HEp-2 cells were fixed in methanol [17 (link)] and incubated with mAbs (50 μg/ml), followed by Alexa Fluor 488-conjugated goat anti-human IgG (2 μg/ml) and Hoechst 33342 (both Life Technologies). Selected slides were sequentially stained with anti-vimentin V9 (2 μg/ml, DAKO) or anti-giantin (1μg/ml, Abcam) followed by Alexa Fluor 568-conjugated donkey anti-mouse antibodies (2 μg/ml, Molecular Probes). Samples were imaged using a Leica SP5 II STED-CW laser scanning confocal microscope.
+ Open protocol
+ Expand
2

Immunofluorescence Staining of Epithelial Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-zona occludens 1 (ZO-1; D7D12), anti-claudin-1 (D5H1D), anti-E-cadherin (24E10), anti-β-catenin (D10A8), anti-snail homolog 2 (slug; C19G7), and anti-rabbit immunoglobulin G (IgG) were from Cell Signaling Technology (Danvers, MA, USA). The other antibodies were obtained from various sources: anti-vimentin (V9; Dako, Carpinteria, CA, USA), anti-cytokeratin-19 (CK-19; HPA002465), and anti-β-actin (AC-15) from Sigma-Aldrich (St. Louis, MO, USA); anti-mouse IgG from GE Healthcare (Buckinghamshire, UK); and all secondary fluorescent antibodies from Invitrogen (Carlsbad, CA, USA).
+ Open protocol
+ Expand
3

Immunohistochemical Staining Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the IHC protocol, a Novolink Max-Polymer detection system was used, according to the manufacturer’s instructions. The detailed protocol is described in Supplementary Figure S1. Primary antibodies included anti-E-cadherin (4A2C7; 1:1000 in BSA 5%; Invitrogen, MA, USA), anti-P-cadherin (56/P-Cadherin; 1:150 in BSA 5%; BD Biosciences, NJ, USA), anti-β-catenin (CAT-5H10; 1:900 in BSA 5%; Invitrogen, MA, USA), and anti-vimentin (V9; 1:1000 in BSA 5%; Dako, Denmark). The negative control refers to cells that were not incubated with the primary antibody. After IHC protocol, each coverslip was removed from the 24-well plate using a small pair of broad-tipped forceps and rinsed in water, counterstained in hematoxylin for 30 s, washed again for 5 to 10 min, dehydrated (at increasing concentrations of ethanol), and diaphanized in xylene, and the slides were mounted using Entellan. Each slide was analyzed using a Nikon Eclipse E600 microscope coupled to a digital camera (Nikon Digital Sight DS-Fi2, Tokyo, Japan). Images were then captured using the Imaging Software NIS-Elements AR Version 4.30.0 (Nikon, Tokyo, Japan).
+ Open protocol
+ Expand
4

Western Blot Analysis of EMT Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in Laemmli buffer and stored at À70 °C. Protein concentrations were determined using the DC protein assay kit (Bio-Rad, Hercules, CA, USA). Samples (20-30 lg of total protein) were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membranes (Hybond â P; GE Healthcare, Little Chalfont, UK). Membranes were blocked for 1 h at room temperature with TBST (20 mM Tris, 137 mM NaCl, 3.8 mM HCl, and 0.1% [v/v] Tween â 20) containing 5% (w/v) nonfat milk powder, and blots were probed with anti-ID1, anti-ID2 or anti-ID3 (Z-8, C-20, C-20; Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-E-cadherin (HECD-1; Abcam, Cambridge, UK), anti-N-cadherin (32; BD Biosciences, Franklin Lakes, NJ, USA), anti-vimentin (V9; Dako, Glostrup, Denmark), anti-Snail (ab117866;
Abcam, Cambridge, UK), anti-MMP-9 (ab35326; Abcam) or anti-actin (C4; EMD Millipore, Billerica, MA, USA) antibodies for 1 h. Membranes were washed and incubated with a secondary antibody (either goat antirabbit or anti-mouse IgG-horseradish peroxidase) (Santa Cruz Biotechnology), washed again and developed for enhanced chemiluminescence using the Amersham ECL-Plus kit according to the manufacturer's instructions (GE Healthcare).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!